Archimedes Pharma Announces Major Fund Raising of GBP65 Million
Reading, England, March 2, 2010 (ots/PRNewswire) - Archimedes Pharma ("Archimedes"), the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also ...
mehr